STERITEK INC
8-K, 1998-12-16
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: CROWN BOOKS CORP, NT 10-Q, 1998-12-16
Next: DYNATRONICS CORP, S-8, 1998-12-16




                           UNITED STATES

                SECURITIES AND EXCHANGE COMMISSION

                    Washington, D.C.   20549

                            FORM 8-K

                         CURRENT REPORT

   Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934



Date of Report (Date of earliest event reported): December 4, 1998

                         Steritek, Inc.                    
     (Exact name of registrant as specified in its charter)

         New Jersey                 0-12547             22-2243703     
(State or other jurisdiction of   (Commission         (I.R.S. Employer
incorporation or organization)    File Number)       Identification No.)

                      121 Moonachie Avenue
                      Moonachie, NJ  07074          
            (Address of principal executive offices)
                           (Zip Code)

                        (201) 460-0500                          
   (Registrant's telephone number, including area code)      


<PAGE>

Item 5. Other Events

     Steritek is pleased to announce that as of December 4, 1998 it entered into
an Agreement and Plan of Merger ("Agreement") with Quality Packaging 
Specialists, Inc. ("QPSI").  Pursuant to that Agreement, QPSI proposes to 
acquire all of the issued and outstanding shares of Steritek Common Stock 
for $5,555,155.40, or approximately $1.39 per share.  The purchase price is 
to be paid in cash at closing to all Steritek shareholders except Albert J. 
Wozniak.  Mr. Wozniak, who holds approximately 65% of Steritek common stock, 
will receive cash and a promissory note.

     The transaction is subject to numerous conditions, including the requisite
approval of Steritek shareholders, the receipt by Steritek of an opinion that 
the financial terms of the transaction are fair to its shareholders, and QPSI's
ability to arrange at least $2,200,000 in financing to consummate the
transaction.  If all conditions are met, the transaction is expected to close on
or about March 1, 1999.



<PAGE>

                 STERITEK, INC. AND SUBSIDIARIES
     
                            SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.

                                Steritek, Inc.              


                              By/s/ James K. Wozniak
                                                                  
 
                                James K. Wozniak, Vice President,
                                 Chief Financial Officer and 
                                 Secretary (principal financial
                                 and accounting officer)         
                    
Date: December 15, 1998



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission